Gemini Therapeutics (GMTX) News Today → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free GMTX Stock Alerts $39.12 +2.66 (+7.30%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 17, 2024 | seekingalpha.comGoogle's public release of Gemini 1.5 should build trust, Deutsche Bank saysApril 15, 2024 | marketbeat.comGemini Therapeutics (NASDAQ:GMTX) Hits New 1-Year High at $32.55Gemini Therapeutics (NASDAQ:GMTX) Reaches New 12-Month High at $32.55April 8, 2024 | marketbeat.comGemini Therapeutics (NASDAQ:GMTX) Sets New 1-Year High at $31.92Gemini Therapeutics (NASDAQ:GMTX) Hits New 1-Year High at $31.92April 1, 2024 | marketbeat.comGemini Therapeutics (NASDAQ:GMTX) Reaches New 1-Year High at $35.40Gemini Therapeutics (NASDAQ:GMTX) Hits New 12-Month High at $35.40March 25, 2024 | marketbeat.comGemini Therapeutics (NASDAQ:GMTX) Sets New 1-Year High at $60.96Gemini Therapeutics (NASDAQ:GMTX) Hits New 52-Week High at $60.96March 19, 2024 | marketbeat.comGemini Therapeutics (NASDAQ:GMTX) Hits New 12-Month High at $67.76Gemini Therapeutics (NASDAQ:GMTX) Sets New 1-Year High at $67.76March 13, 2024 | marketbeat.comGemini Therapeutics (NASDAQ:GMTX) Hits New 52-Week High at $66.32Gemini Therapeutics (NASDAQ:GMTX) Hits New 1-Year High at $66.32February 26, 2024 | washingtonpost.comGoogle takes down Gemini AI image generator. Here’s what you need to know.February 26, 2024 | nypost.com‘White privilege is f–king real’: Google Gemini product lead’s old tweets allegedly resurface amid ‘woke’ AI image fiascoJune 24, 2023 | benzinga.com(SPAC) Special Purpose Acquisition Investigation: PRDS, GMTX, SNTI, TNGX - Contact Shareholder Rights Law Firm Johnson FistelJune 1, 2023 | barrons.comBronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Gemini Therapeutics, Inc. (GMTX) InvestigationMarch 8, 2023 | marketbeat.comGemini Therapeutics, Inc. (NASDAQ:GMTX) Shares Sold by Ergoteles LLCErgoteles LLC lowered its position in shares of Gemini Therapeutics, Inc. (NASDAQ:GMTX - Get Rating) by 13.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 92,200 shares of the company's stock after selling 13,900 shares durinJanuary 19, 2023 | marketbeat.comAssenagon Asset Management S.A. Acquires 66,467 Shares of Gemini Therapeutics, Inc. (NASDAQ:GMTX)Assenagon Asset Management S.A. raised its holdings in Gemini Therapeutics, Inc. (NASDAQ:GMTX - Get Rating) by 423.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 82,171 shares of the company's stockJanuary 13, 2023 | markets.businessinsider.comThe Winklevoss' Gemini terminates its yield product as dispute between the crypto exchange and DCG escalatesJanuary 1, 2023 | usatoday.comGemini HoroscopeDecember 27, 2022 | finance.yahoo.comDisc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic ProtoporphyriaOctober 31, 2022 | finance.yahoo.comDisc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP)September 27, 2022 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBTX, PBFX, EVOP, GMTXSeptember 26, 2022 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMTX, FMTX, TRQ, SGFYSeptember 16, 2022 | markets.businessinsider.comSHAREHOLDER UPDATE: Halper Sadeh LLC Investigates GMTX, RMED, LOTZSeptember 6, 2022 | markets.businessinsider.comSHAREHOLDER NOTICE: Halper Sadeh LLP Investigates BHVN, DRE, PLD, GMTX, SAFEAugust 25, 2022 | apnews.comThe M&A Class Action Firm Announces the Investigation of Gemini Therapeutics, Inc. – GMTXAugust 24, 2022 | benzinga.comSHAREHOLDER ALERT: Weiss Law Reminds, LOTZ, GMTX, AAWW, and CCXI Shareholders About Its Ongoing InvestigationsAugust 12, 2022 | apnews.comGEMINI THERAPEUTICS, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of GMTX and Encourages Investors to Contact the FirmAugust 12, 2022 | marketwatch.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Gemini Therapeutics, Inc. MergerAugust 11, 2022 | benzinga.comSHAREHOLDER ALERT: Weiss Law Investigates Gemini Therapeutics, Inc.August 11, 2022 | apnews.comSHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates GMTX, MANT, ZY, LOTZAugust 11, 2022 | apnews.comGMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to ShareholdersAugust 10, 2022 | apnews.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Gemini Therapeutics, Inc. (Nasdaq – GMTX)August 10, 2022 | finance.yahoo.comBlood disorder startup goes public by merging with embattled biotechAugust 10, 2022 | seekingalpha.comGemini stock soars 35% on merger with Disc Medicine in all-stock dealAugust 10, 2022 | nasdaq.comGemini Therapeutics, Disc Medicine Announce All-stock MergerAugust 10, 2022 | finance.yahoo.comGemini Therapeutics and Disc Medicine Announce Merger AgreementAugust 10, 2022 | marketbeat.comTrading was temporarily halted for "GMTX" at 07:08 AM with a stated reason of "News pending."April 15, 2022 | finance.yahoo.comInsider Buying: Braden Leonard Just Spent US$75k On Gemini Therapeutics, Inc. (NASDAQ:GMTX) SharesApril 12, 2022 | finance.yahoo.comGemini Therapeutics, Inc. (GMTX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?March 11, 2022 | marketbeat.comHC Wainwright Lowers Gemini Therapeutics (NASDAQ:GMTX) to NeutralHC Wainwright cut Gemini Therapeutics from a "buy" rating to a "neutral" rating in a report on Friday.March 10, 2022 | seekingalpha.comGemini Therapeutics GAAP EPS of -$1.78 beats by $0.17March 10, 2022 | finance.yahoo.comGemini Therapeutics Reports 2021 Financial ResultsMarch 7, 2022 | marketbeat.comGemini Therapeutics (NASDAQ:GMTX) Upgraded to "Buy" by Zacks Investment ResearchZacks Investment Research raised Gemini Therapeutics from a "hold" rating to a "buy" rating and set a $1.50 price target for the company in a report on Monday.March 3, 2022 | benzinga.comWhat 5 Analyst Ratings Have To Say About Gemini TherapeuticsMarch 2, 2022 | bizjournals.comTwo more Cambridge biotechs cutting staffMarch 1, 2022 | uk.investing.comAPi Group Shares Slide After Q4 Results, Clocks 27% Revenue GrowthMarch 1, 2022 | benzinga.comJefferies Downgrades Gemini Therapeutics to Hold, Lowers Price Target to $1.5March 1, 2022 | seekingalpha.comGemini extends losses as strategic review prompts Jefferies downgradeFebruary 28, 2022 | seekingalpha.comGemini Therapeutics names interim CEO, announces job cutsFebruary 28, 2022 | finance.yahoo.comGemini Therapeutics Provides Corporate UpdateJanuary 25, 2022 | benzinga.comSVB Leerink Maintains Outperform on Gemini Therapeutics, Lowers Price Target to $10January 24, 2022 | marketbeat.comGemini Therapeutics (NASDAQ:GMTX) Price Target Lowered to $10.00 at SVB LeerinkSVB Leerink cut their target price on Gemini Therapeutics from $15.00 to $10.00 and set an "outperform" rating for the company in a research note on Monday.January 11, 2022 | nasdaq.comGemini Therapeutics, Inc. Common Stock (GMTX) Get Gemini Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Time is Running Out - June 25th Deadline Approaching! (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry. That will slam shut June 25. GMTX Media Mentions By Week GMTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GMTX News Sentiment▼0.000.73▲Average Medical News Sentiment GMTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GMTX Articles This Week▼00▲GMTX Articles Average Week Get Gemini Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Organon & Co. News Ionis Pharmaceuticals News BridgeBio Pharma News Cytokinetics News Madrigal Pharmaceuticals News Apellis Pharmaceuticals News Alpine Immune Sciences News Nuvalent News Alkermes News Perrigo News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GMTX) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored